More symptomatic upper GI events with rofecoxib than celecoxib

被引：0

作者：

机构：

来源：

Reactions Weekly | 2005年 / 1072卷 / 1期

关键词：

Primary Care; Celecoxib; Rate Ratio; Thromboembolic Event; Rofecoxib;

D O I：

10.2165/00128415-200510720-00009

中图分类号：

学科分类号：

摘要：

引用

页码：5 / 5

共 50 条

[21] Celecoxib affects BP control less than rofecoxib in elderly patients
Reactions Weekly, 2001, 860 (1) : 5 - 5
[22] Rofecoxib: greater risk of MI and sudden cardiac death than celecoxib
Reactions Weekly, 2004, 1020 (1) : 4 - 4
[23] Celecoxib has better GI tolerability than diclofenac
Reactions Weekly, 2002, 903 (1) : 3 - 3
[24] Less GI disorders with celecoxib than conventional NSAIDs
Reactions Weekly, 1998, 731 (1) : 3 - 3
[25] Rofecoxib [`Vioxx'] was associated with significantly fewer adverse gastrointestinal (GI) events
Reactions Weekly, 2000, 796 (1) : 3 - 3
[26] A comparison of reported thromboembolic events between rofecoxib and celecoxib using observational data
Kasliwal, R
Layton, D
Harris, S
Wilton, L
Shakir, SAW
DRUG SAFETY, 2005, 28 (10) : 934 - 934
[27] Fewer GI ulcers with celecoxib + aspirin than naproxen + aspirin
Reactions Weekly, 2006, 1111 (1) : 5 - 5
[28] Adverse events of upper GI endoscopy
Ben-Menachem, Tamir
Decker, G. Anton
Early, Dayna S.
Evans, Jerry
Fanelli, Robert D.
Fisher, Deborah A.
Fisher, Laurel
Fukami, Norio
Hwang, Joo Ha
Ikenberry, Steven O.
Jain, Rajeev
Jue, Terry L.
Khan, Khalid M.
Krinsky, Mary L.
Malpas, Phyllis M.
Maple, John T.
Sharaf, Ravi N.
Dominitz, Jason A.
Cash, Brooks D.
GASTROINTESTINAL ENDOSCOPY, 2012, 76 (04) : 707 - 718
[29] COX-2s increase BP, rofecoxib greater effect than celecoxib
Reactions Weekly, 2005, 1040 (1) : 5 - 5
[30] A Comparison of Reported Gastrointestinal and Thromboembolic Events Between Rofecoxib and Celecoxib Using Observational Data
Rachna Kasliwal
Deborah Layton
Scott Harris
Lynda Wilton
Saad AW Shakir
Drug Safety, 2005, 28 : 803 - 816

← 1 2 3 4 5 →